UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

External comparators and estimands

Frontiers in Drug Safety and Regulation, 2024-02, Vol.3

Rippin, Gerd

2024

Link zum Volltext

Verfügbarkeit prüfen

External Comparator Cohort studies - clarification of terminology

Frontiers in Drug Safety and Regulation, 2024-01, Vol.3

2024

Link zum Volltext

Verfügbarkeit prüfen

Investigating the trends in patient-reported outcomes pre-treatment and implications to efficacy analyses: A post-hoc analysis of a cancer clinical trial

Contemporary clinical trials communications, 2022-12, Vol.30, p.101021-101021, Article 101021

2022

Link zum Volltext

Verfügbarkeit prüfen

MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria

Cancer medicine (Malden, MA), 2020-07, Vol.9 (13), p.4512-4526

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

The New England journal of medicine, 2004-08, Vol.351 (9), p.884-892

2004

Link zum Volltext

Verfügbarkeit prüfen

A Review of Causal Inference for External Comparator Arm Studies

Drug safety, 2022-08, Vol.45 (8), p.815-837

2022

Link zum Volltext

Verfügbarkeit prüfen

Quantitative morphometric analysis of the submucous plexus in age-related control groups

Virchows Archiv : an international journal of pathology, 2004-03, Vol.444 (3), p.239-246

2004

Link zum Volltext

Verfügbarkeit prüfen

A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement Therapy

Chest, 2008-10, Vol.134 (4), p.724-732

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

BMC cancer, 2014-10, Vol.14 (1), p.748-748, Article 748

2014

Link zum Volltext

Verfügbarkeit prüfen

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

Journal for immunotherapy of cancer, 2015-06, Vol.3 (1), p.26-26, Article 26

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of Myeloproliferative Neoplasms (MPNs) on Health-Related Quality of Life (HRQOL) and Medical Resource Utilization: Results from the MERGE Registry

Blood, 2018-11, Vol.132 (Supplement 1), p.4311-4311

2018

Link zum Volltext

Verfügbarkeit prüfen

Myeloproliferative Neoplasms in Asia, Including Middle East, Turkey, and Algeria: Epidemiological Indices and Treatment Practice Patterns from the Multinational, Multicenter, Observational MERGE Registry

Blood, 2018-11, Vol.132 (Supplement 1), p.5461-5461

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease

The American journal of cardiology, 2002, Vol.89 (1), p.12-17

2002

Link zum Volltext

Verfügbarkeit prüfen

A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement Therapy : A Pooled Analysis of Five Studies With Recombinant Surfactant Protein-C Surfactant (Venticute)

Chest, 2008-10, Vol.134 (4), p.724-732

2008

Link zum Volltext

Verfügbarkeit prüfen

Angiographic analysis of immediate and long-term results of PTCR vs. PTCA in complex lesions (COBRA study)

Catheterization and cardiovascular interventions, 2001-07, Vol.53 (3), p.359-367

2001

Link zum Volltext

Verfügbarkeit prüfen

Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease

The American journal of cardiology, 2002-04, Vol.89 (8), p.901-908

2002

Link zum Volltext

Verfügbarkeit prüfen

Surfactant Replacement Therapy in ARDS: Response

Chest, 2009-07, Vol.136 (1), p.321-322

2009

Link zum Volltext

Verfügbarkeit prüfen

A phase I/IIa study of the mRNA based cancer vaccine CV9103 prepared with the RNActive technology results in distinctly longer survival than predicted by the Halabi Nomogram which correlates with the induction of antigen-specific immune responses

Journal for immunotherapy of cancer, 2013-11, Vol.1 (S1), p.P219-P219, Article P219

2013

Link zum Volltext

Verfügbarkeit prüfen

Messenger RNA vaccination and B-cell responses in NSCLC patients

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.2573-2573

2012

Link zum Volltext

Verfügbarkeit prüfen

Surfactant replacement therapy in ARDS

Chest, 2009-07, Vol.136 (1), p.321

2009

Link zum Volltext

Verfügbarkeit prüfen

S34.3: Inference from empty contingency tables

Biometrical journal, 2004-03, Vol.46 (S1), p.73-73

2004

Link zum Volltext

Verfügbarkeit prüfen

Influence of HMG–CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion

International journal of cardiology, 2002, Vol.82 (1), p.25-31

2002

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of Formulae for Calculating Cost-Efficient Sample Sizes of Case-Control Studies with an Internal Validation Scheme

Biometrical journal, 2000-11, Vol.42 (7), p.887-894

Rippin, Gerd

2000

Link zum Volltext

Verfügbarkeit prüfen

Reduction of Polymerization Shrinkage Stress and Marginal Microleakage Using Soft-Start Polymerization

Journal of esthetic and restorative dentistry, 2003-03, Vol.15 (2), p.93-103

2003

Link zum Volltext

Verfügbarkeit prüfen

Therapiemonitoring mittels 2-[18F]-FDG-Positronenemissionstomographie nach neoadjuvanter Strahlenbehandlung des Mundhöhlenkarzinoms

Strahlentherapie und Onkologie, 2001-03, Vol.177 (3), p.145-152

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

ThemaPeripheral Vascular Disease

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(39)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

External comparators and estimands

External Comparator Cohort studies - clarification of terminology

Investigating the trends in patient-reported outcomes pre-treatment and implications to efficacy analyses: A post-hoc analysis of a cancer clinical trial

MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

A Review of Causal Inference for External Comparator Arm Studies

Quantitative morphometric analysis of the submucous plexus in age-related control groups

A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement Therapy

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

Impact of Myeloproliferative Neoplasms (MPNs) on Health-Related Quality of Life (HRQOL) and Medical Resource Utilization: Results from the MERGE Registry

Myeloproliferative Neoplasms in Asia, Including Middle East, Turkey, and Algeria: Epidemiological Indices and Treatment Practice Patterns from the Multinational, Multicenter, Observational MERGE Registry

Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease

A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement Therapy : A Pooled Analysis of Five Studies With Recombinant Surfactant Protein-C Surfactant (Venticute)

Angiographic analysis of immediate and long-term results of PTCR vs. PTCA in complex lesions (COBRA study)

Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease

Surfactant Replacement Therapy in ARDS: Response

A phase I/IIa study of the mRNA based cancer vaccine CV9103 prepared with the RNActive technology results in distinctly longer survival than predicted by the Halabi Nomogram which correlates with the induction of antigen-specific immune responses

Messenger RNA vaccination and B-cell responses in NSCLC patients

Surfactant replacement therapy in ARDS

S34.3: Inference from empty contingency tables

Influence of HMG–CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion

A Comparison of Formulae for Calculating Cost-Efficient Sample Sizes of Case-Control Studies with an Internal Validation Scheme

Reduction of Polymerization Shrinkage Stress and Marginal Microleakage Using Soft-Start Polymerization

Therapiemonitoring mittels 2-[18F]-FDG-Positronenemissionstomographie nach neoadjuvanter Strahlenbehandlung des Mundhöhlenkarzinoms

Aktive Filter

Suchergebnisse filtern